Ryo Tanabe

An 83‐year‐old patient with RET fusion‐positive non‐small cell lung cancer experiencing severe hepatic disorder due to selpercatinib administration

T. Isobe, K. Nakashima, Y. Tsubata, 2023, Respirology case reports.